Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $74
Benzinga Newsdesk 16 hours ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $74.
Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $74.